NASDAQ:VXRT - Vaxart Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.45 -0.06 (-2.39 %)
(As of 11/13/2018 01:44 PM ET)
Previous Close$2.51
Today's Range$2.45 - $2.51
52-Week Range$2.37 - $9.46
Volume600 shs
Average Volume93,041 shs
Market Capitalization$18.85 million
P/E RatioN/A
Dividend YieldN/A
Beta0.01
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.

Receive VXRT News and Ratings via Email

Sign-up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VXRT
Previous SymbolNASDAQ:NABI
CUSIPN/A
Phone650-550-3500

Debt

Debt-to-Equity Ratio0.12
Current Ratio2.90
Quick Ratio2.90

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$8.90 million
Price / Sales1.97
Cash FlowN/A
Price / CashN/A
Book Value($11.02) per share
Price / Book-0.22

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-3,400,000.00
Net Margins-330.79%
Return on Equity-310.49%
Return on Assets-42.03%

Miscellaneous

Employees16
Outstanding Shares7,140,000
Market Cap$18.85 million
OptionableNot Optionable

Vaxart (NASDAQ:VXRT) Frequently Asked Questions

What is Vaxart's stock symbol?

Vaxart trades on the NASDAQ under the ticker symbol "VXRT."

When did Vaxart's stock split? How did Vaxart's stock split work?

Vaxart's stock reverse split on Wednesday, February 14th 2018. The 1-11 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of Vaxart stock prior to the reverse split would have 9 shares after the split.

How were Vaxart's earnings last quarter?

Vaxart Inc (NASDAQ:VXRT) announced its earnings results on Friday, November, 9th. The biotechnology company reported ($0.92) earnings per share (EPS) for the quarter. The biotechnology company earned $0.28 million during the quarter. Vaxart had a negative net margin of 330.79% and a negative return on equity of 310.49%. View Vaxart's Earnings History.

When is Vaxart's next earnings date?

Vaxart is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Vaxart.

Has Vaxart been receiving favorable news coverage?

Media stories about VXRT stock have trended neutral on Tuesday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vaxart earned a news impact score of 0.2 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are some of Vaxart's key competitors?

Who are Vaxart's key executives?

Vaxart's management team includes the folowing people:
  • Dr. Wouter W. Latour M.B.A., M.D., MBA, Pres, CEO & Director (Age 60)
  • Dr. Sean N. Tucker, Founder & Chief Scientific Officer (Age 50)
  • Mr. John M. Harland M.B.A., CPA, CFO & Sec. (Age 66)
  • Mr. Brant Biehn, Sr. VP of Commercial Operations
  • Dr. David N. Taylor, Chief Medical Officer (Age 69)

How do I buy shares of Vaxart?

Shares of VXRT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vaxart's stock price today?

One share of VXRT stock can currently be purchased for approximately $2.51.

How big of a company is Vaxart?

Vaxart has a market capitalization of $18.85 million and generates $8.90 million in revenue each year. Vaxart employs 16 workers across the globe.

What is Vaxart's official website?

The official website for Vaxart is http://www.vaxart.com.

How can I contact Vaxart?

Vaxart's mailing address is 290 Utah Ave. Suite 200, South San Francisco CA, 94080. The biotechnology company can be reached via phone at 650-550-3500 or via email at [email protected]


MarketBeat Community Rating for Vaxart (NASDAQ VXRT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  148 (Vote Outperform)
Underperform Votes:  137 (Vote Underperform)
Total Votes:  285
MarketBeat's community ratings are surveys of what our community members think about Vaxart and other stocks. Vote "Outperform" if you believe VXRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VXRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2018 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel